Your browser doesn't support javascript.
loading
Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients.
Bassi, Jessica; Giannini, Olivier; Silacci-Fregni, Chiara; Pertusini, Laura; Hitz, Paolo; Terrot, Tatiana; Franzosi, Yves; Muoio, Francesco; Saliba, Christian; Meury, Marcel; Dellota, Exequiel A; Dillen, Josh R; Hernandez, Patrick; Czudnochowski, Nadine; Cameroni, Elisabetta; Beria, Nicola; Ventresca, Mariangela; Badellino, Alberto; Lavorato-Hadjeres, Soraya; Lecchi, Elisabetta; Bonora, Tecla; Mattiolo, Matteo; Trinci, Guido; Garzoni, Daniela; Bonforte, Giuseppe; Forni-Ogna, Valentina; Giunzioni, Davide; Berwert, Lorenzo; Gupta, Ravindra K; Ferrari, Paolo; Ceschi, Alessandro; Cippà, Pietro; Corti, Davide; Lanzavecchia, Antonio; Piccoli, Luca.
Afiliação
  • Bassi J; Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Giannini O; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.
  • Silacci-Fregni C; Department of Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Pertusini L; Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Hitz P; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Terrot T; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.
  • Franzosi Y; Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Muoio F; Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Saliba C; Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Meury M; Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Dellota EA; Vir Biotechnology, San Francisco, California, United States of America.
  • Dillen JR; Vir Biotechnology, San Francisco, California, United States of America.
  • Hernandez P; Vir Biotechnology, San Francisco, California, United States of America.
  • Czudnochowski N; Vir Biotechnology, San Francisco, California, United States of America.
  • Cameroni E; Vir Biotechnology, San Francisco, California, United States of America.
  • Beria N; Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Ventresca M; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Badellino A; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Lavorato-Hadjeres S; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Lecchi E; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Bonora T; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Mattiolo M; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Trinci G; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Garzoni D; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Bonforte G; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Forni-Ogna V; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Giunzioni D; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Berwert L; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Gupta RK; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Ferrari P; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, United Kingdom.
  • Ceschi A; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Cippà P; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.
  • Corti D; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Lanzavecchia A; Clinical School, University of New South Wales, Sydney, Australia.
  • Piccoli L; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.
PLoS One ; 17(2): e0263328, 2022.
Article em En | MEDLINE | ID: mdl-35143540
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testes de Neutralização / Diálise Renal / Vacinação / Anticorpos Neutralizantes / SARS-CoV-2 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testes de Neutralização / Diálise Renal / Vacinação / Anticorpos Neutralizantes / SARS-CoV-2 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça